555 related articles for article (PubMed ID: 19380660)
1. Efficacy and safety of combination Acitretin and Pioglitazone therapy in patients with moderate to severe chronic plaque-type psoriasis: a randomized, double-blind, placebo-controlled clinical trial.
Mittal R; Malhotra S; Pandhi P; Kaur I; Dogra S
Arch Dermatol; 2009 Apr; 145(4):387-93. PubMed ID: 19380660
[TBL] [Abstract][Full Text] [Related]
2. Combining etanercept and acitretin in the therapy of chronic plaque psoriasis: a 24-week, randomized, controlled, investigator-blinded pilot trial.
Gisondi P; Del Giglio M; Cotena C; Girolomoni G
Br J Dermatol; 2008 Jun; 158(6):1345-9. PubMed ID: 18410408
[TBL] [Abstract][Full Text] [Related]
3. Pilot trial: Pioglitazone versus placebo in patients with plaque psoriasis (the P6).
Shafiq N; Malhotra S; Pandhi P; Gupta M; Kumar B; Sandhu K
Int J Dermatol; 2005 Apr; 44(4):328-33. PubMed ID: 15811089
[TBL] [Abstract][Full Text] [Related]
4. Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis.
Tyring S; Gordon KB; Poulin Y; Langley RG; Gottlieb AB; Dunn M; Jahreis A
Arch Dermatol; 2007 Jun; 143(6):719-26. PubMed ID: 17576937
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks.
Sivanesan SP; Gattu S; Hong J; Chavez-Frazier A; Bandow GD; Malick F; Kricorian G; Koo J
J Am Acad Dermatol; 2009 Nov; 61(5):793-8. PubMed ID: 19766350
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of acitretin in three fixed doses of 25, 35 and 50 mg in adult patients with severe plaque type psoriasis: a randomized, double blind, parallel group, dose ranging study.
Dogra S; Jain A; Kanwar AJ
J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e305-11. PubMed ID: 22816881
[TBL] [Abstract][Full Text] [Related]
7. Efficiency of acitretin in combination with UV-B in the treatment of severe psoriasis.
Ruzicka T; Sommerburg C; Braun-Falco O; Köster W; Lengen W; Lensing W; Letzel H; Meigel WN; Paul E; Przybilla B
Arch Dermatol; 1990 Apr; 126(4):482-6. PubMed ID: 2138875
[TBL] [Abstract][Full Text] [Related]
8. A randomized, multicenter, double-blind, placebo-controlled phase 2 trial of ISA247 in patients with chronic plaque psoriasis.
Bissonnette R; Papp K; Poulin Y; Lauzon G; Aspeslet L; Huizinga R; Mayo P; Foster RT; Yatscoff RW; Maksymowych WP;
J Am Acad Dermatol; 2006 Mar; 54(3):472-8. PubMed ID: 16488299
[TBL] [Abstract][Full Text] [Related]
9. Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. The European FK 506 Multicentre Psoriasis Study Group.
Arch Dermatol; 1996 Apr; 132(4):419-23. PubMed ID: 8629845
[TBL] [Abstract][Full Text] [Related]
10. Infliximab treatment results in significant improvement in the quality of life of patients with severe psoriasis: a double-blind placebo-controlled trial.
Feldman SR; Gordon KB; Bala M; Evans R; Li S; Dooley LT; Guzzo C; Patel K; Menter A; Gottlieb AB
Br J Dermatol; 2005 May; 152(5):954-60. PubMed ID: 15888152
[TBL] [Abstract][Full Text] [Related]
11. Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial.
Gottlieb AB; Evans R; Li S; Dooley LT; Guzzo CA; Baker D; Bala M; Marano CW; Menter A
J Am Acad Dermatol; 2004 Oct; 51(4):534-42. PubMed ID: 15389187
[TBL] [Abstract][Full Text] [Related]
12. Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial.
Leonardi C; Langley RG; Papp K; Tyring SK; Wasel N; Vender R; Unnebrink K; Gupta SR; Valdecantos WC; Bagel J
Arch Dermatol; 2011 Apr; 147(4):429-36. PubMed ID: 21173304
[TBL] [Abstract][Full Text] [Related]
13. Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension.
van de Kerkhof PC; Segaert S; Lahfa M; Luger TA; Karolyi Z; Kaszuba A; Leigheb G; Camacho FM; Forsea D; Zang C; Boussuge MP; Paolozzi L; Wajdula J
Br J Dermatol; 2008 Nov; 159(5):1177-85. PubMed ID: 18673365
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial.
Kimball AB; Gordon KB; Langley RG; Menter A; Chartash EK; Valdes J;
Arch Dermatol; 2008 Feb; 144(2):200-7. PubMed ID: 18283176
[TBL] [Abstract][Full Text] [Related]
15. Folic acid supplementation during treatment of psoriasis with methotrexate: a randomized, double-blind, placebo-controlled trial.
Salim A; Tan E; Ilchyshyn A; Berth-Jones J
Br J Dermatol; 2006 Jun; 154(6):1169-74. PubMed ID: 16704650
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of acitretin and commercial tanning bed therapy for psoriasis.
Carlin CS; Callis KP; Krueger GG
Arch Dermatol; 2003 Apr; 139(4):436-42. PubMed ID: 12707089
[TBL] [Abstract][Full Text] [Related]
17. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy of acitretin therapy for nail psoriasis.
Tosti A; Ricotti C; Romanelli P; Cameli N; Piraccini BM
Arch Dermatol; 2009 Mar; 145(3):269-71. PubMed ID: 19289755
[TBL] [Abstract][Full Text] [Related]
19. Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis.
Pearce DJ; Klinger S; Ziel KK; Murad EJ; Rowell R; Feldman SR
Arch Dermatol; 2006 Aug; 142(8):1000-4. PubMed ID: 16924049
[TBL] [Abstract][Full Text] [Related]
20. Oral liarozole vs. acitretin in the treatment of ichthyosis: a phase II/III multicentre, double-blind, randomized, active-controlled study.
Verfaille CJ; Vanhoutte FP; Blanchet-Bardon C; van Steensel MA; Steijlen PM
Br J Dermatol; 2007 May; 156(5):965-73. PubMed ID: 17263800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
